0001415889-21-000330.txt : 20210115
0001415889-21-000330.hdr.sgml : 20210115
20210115182727
ACCESSION NUMBER: 0001415889-21-000330
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210113
FILED AS OF DATE: 20210115
DATE AS OF CHANGE: 20210115
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Chapman Steven Leonard
CENTRAL INDEX KEY: 0001711968
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37478
FILM NUMBER: 21533312
MAIL ADDRESS:
STREET 1: 201 INDUSTRIAL ROAD, SUITE 410
CITY: SAN CARLOS
STATE: CA
ZIP: 94070
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Natera, Inc.
CENTRAL INDEX KEY: 0001604821
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071]
IRS NUMBER: 010894487
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 201 INDUSTRIAL ROAD
STREET 2: SUITE 410
CITY: SAN CARLOS
STATE: CA
ZIP: 94070
BUSINESS PHONE: 650-249-9090
MAIL ADDRESS:
STREET 1: 201 INDUSTRIAL ROAD
STREET 2: SUITE 410
CITY: SAN CARLOS
STATE: CA
ZIP: 94070
4
1
form4-01152021_030117.xml
X0306
4
2021-01-13
0001604821
Natera, Inc.
NTRA
0001711968
Chapman Steven Leonard
C/O NATERA, INC.
201 INDUSTRIAL RD SUITE 410
SAN CARLOS
CA
94070
true
true
false
false
CHIEF EXECUTIVE OFFICER
Common Stock
2021-01-13
4
M
0
1118
10.41
A
38282
D
Common Stock
2021-01-13
4
M
0
1042
10.73
A
39324
D
Common Stock
2021-01-13
4
M
0
1526
9.29
A
40850
D
Common Stock
2021-01-13
4
M
0
1042
13.01
A
41892
D
Common Stock
2021-01-13
4
M
0
1042
20.27
A
42394
D
Common Stock
2021-01-13
4
M
0
2385
25.46
A
45319
D
Common Stock
2021-01-13
4
S
0
8155
115
D
37164
D
Stock Option (right to buy)
10.41
2021-01-13
4
M
0
1118
0
D
2027-06-08
Common Stock
1118
9719
D
Stock Option (right to buy)
10.73
2021-01-13
4
M
0
1042
0
D
2027-07-13
Common Stock
1042
4063
D
Stock Option (right to buy)
9.29
2021-01-13
4
M
0
1526
0
D
2028-03-08
Common Stock
1526
47161
D
Stock Option (right to buy)
13.01
2021-01-13
4
M
0
1042
0
D
2029-01-10
Common Stock
1042
52812
D
Stock Option (right to buy)
20.27
2021-01-13
4
M
0
1042
0
D
2029-04-11
Common Stock
1042
59062
D
Stock Option (right to buy)
25.46
2021-01-13
4
M
0
2385
0
D
2030-03-26
Common Stock
2385
39646
D
The sales reported in this Form 4 effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 16, 2020.
The option shares vest over four years. 25% of the option shares vested and became exercisable on March 21, 2018 and the remaining shares vest in 36 equal monthly installments thereafter.
The option shares vest over four years. 25% of the option shares vested and became exercisable on March 12, 2018 and the remaining shares vest in 36 equal monthly installments thereafter.
The option shares vest over four years. 25% of the option shares vested and became exercisable on March 9, 2019 and the remaining shares vest in 36 equal monthly installments thereafter.
The option shares vest over four years. 25% of the option shares vested and became exercisable on January 2, 2020 and the remaining shares vest in 36 equal monthly installments thereafter.
The option shares vest over four years. 25% of the option shares vested and became exercisable on March 22, 2020 and the remaining shares vest in 36 equal monthly installments thereafter.
The option vests upon the Reporting Person achieving certain milestones relating to a combination of the passage of time and the Reporting Person achieving certain milestones relating to the Issuer's stock price. As of October 1, 2020, the Company's Board of Director determined the performance criteria had been met with respect to 37,500 shares.
/s/ Tami Chen, Attorney-in-Fact
2021-01-15